Listen
CASARENEL (adapalene, benzoyl peroxide) - Acne
Opinions on drugs -
Posted on
Sep 11 2025
Reason for request
Inclusion on list
Summary of opinion
Favourable opinion for reimbursement in the cutaneous treatment of acne vulgaris when comedones, papules and pustules are present, in adults, adolescents and children aged 9 years and older.
Clinical Benefit
| Moderate |
The clinical benefit of CASARENEL 0.1%/2.5% (adapalene, benzoyl peroxide) gel is moderate in the treatment of acne vulgaris when comedones, papules and pustules are present. |
Clinical Added Value
| no clinical added value |
This medicinal product is a hybrid that provides no clinical added value (CAV V) compared to the reference medicinal product already listed. |
Documents
English version
Contact Us
Évaluation des médicaments
